06.27.2022
Hebrew SeniorLife: “New Study Finds a Mediterranean-Style Diet May Reduce Likelihood of Frailty: Frailty occurs in 10-15% of the population but a new study, published in The American Journal of Clinical Nutrition, found that consuming a Mediterranean-style diet may prevent frailty. Changing their diet can help people prevent frailty”
06.24.2022
Akston Biosciences: “Biolexis and Akston Biosciences Announce Encouraging Top-Line Results from Phase II/III Trial of their Thermostable 2nd Gen COVID-19 Vaccine”
06.15.2022
Hebrew SeniorLife: “Hebrew SeniorLife Appoints New Medical Director for Hebrew Rehabilitation Center: Dr. Matthew Shuster brings years of experience in compassionate and coordinated care”
05.12.2022
Akston Biosciences: “Akston Biosciences Doses First Participants in Phase II Clinical Trial for Shelf-Stable COVID-19 Booster”
05.05.2022
Hebrew SeniorLife: “Hebrew SeniorLife Honors Nursing Staff at Academic Celebration: Carline Cenat, Registered Nurse, recognized as R.N. of the Year and Dadie Petit-Frere, P.C.A., as Personal Care Associate of the Year”
04.25.2022
Hebrew SeniorLife: “Helping Senior Homeowners Move Forward” Webinar, April 27: Free Info Session for Real Estate Professionals to Offer Tips to Address Seller Hesitancy”
04.22.2022
Hebrew SeniorLife: “Hebrew SeniorLife Receives State Job Training Grants: The funds will be used to provide training and placement services to prepare 105 unemployed and underemployed participants for CNA positions”
04.21.2022
Hebrew SeniorLife: “Jazz Singer Donna Byrne Kicks off 23rd Year of Orchard Cove Scholarship Fund”
04.12.2022
Akston Biosciences: “Akston Biosciences CEO to Present at the World Vaccine Congress: Akston’s AKS-452 COVID-19 vaccine is shortlisted for Best New Vaccine Technology/Platform in Vaccine Industry Excellence (ViE) Awards”
04.07.2022
Akston Biosciences: “Akston Biosciences Doses First Volunteers in Phase II/III Clinical Trial of Low Cost, Shelf Stable COVID-19 Vaccine”
03.31.2022
Hebrew SeniorLife: “Researchers develop scoring tool to measure severity of delirium: Severity scores can guide patient-centered care, study suggests”
Akston Biosciences: “Akston Biosciences Receives Regulatory Approval for Phase II Clinical Trial for Shelf-Stable COVID-19 Vaccine Booster”
